CyberKnife cancer treatment in Turkey | Process, benefits & cost

What is Cyberknife treatment?

Looking for a non-surgical way to treat your tumor effectively? CyberKnife represents a revolution in cancer care. This advanced stereotactic radiosurgery (SRS) system delivers highly targeted radiation directly to tumors, minimizing damage to healthy tissue.

Unlike traditional radiosurgery, CyberKnife adapts to the shape of the tumor and body movement, making it possible to treat even delicate areas, such as the brain, spine, or spinal cord. For patients previously considered inoperable, it opens new treatment options and hope.

The advantages of CyberKnife treatment in Turkey include:

• Non-invasive and pain-free: No incisions, reduced recovery time.
• High precision: Sub-millimeter accuracy protects healthy tissue.
• Personalized treatment: Expert oncology teams tailor each plan to the patient's needs.

Take the first step toward a safer, more precise cancer treatment! Consult with our specialists in Turkey to explore your personalized CyberKnife plan.

CyberKnife cancer treatment: Applicable cases

CyberKnife treatment is a versatile, non-invasive option suitable for various areas of the body where radiation therapy is effective. It can target both malignant (cancerous) and benign (non-cancerous) growths, as well as metastatic tumors, arteriovenous malformations, and certain functional conditions. Patients should always consult with their doctor to determine if CyberKnife aligns with their specific medical needs.

This treatment is particularly effective for:

• Brain tumors (primary or secondary) and tumors of the head and neck regions.
• Spinal tumors affecting vertebrae or surrounding tissue.
• Soft tissue tumors in organs such as the lungs, liver, kidneys, and pancreas.
• Specific conditions like acoustic neuromas, meningiomas, skull base tumors, and pituitary tumors.
• Eye cancers and recurrent or residual tumors.
• Arteriovenous malformations.
• Certain functional disorders, including trigeminal neuralgia.
• Prostate cancer.

With its precision and adaptability, CyberKnife can treat tumors in delicate or difficult-to-reach locations, offering patients a safe, effective, and personalized approach.

Discover if CyberKnife treatment is suitable for your condition. Consult our specialists in Turkey for a personalized evaluation and treatment plan.

How does the CyberKnife therapy session proceed?

A typical session of Cyberknife therapy involves several key steps:

Imaging exam

A computed tomography (CT),magnetic resonance imaging (MRI),angiography, or PET scan is performed before the initial radiation treatment to precisely identify the size, shape, and placement of the target area. This information is utilized to create the treatment planning strategy and to define the "radiation field," or the area that the rays should target.

Treatment planning

The imaging data is sent to the treatment planning system, where a trained medical doctor identifies:

• The tumor to target
• Nearby critical structures to protect
• The radiation dose required
• The number of sessions (usually 1–5)

Using this information, a medical physicist designs the most effective and safe treatment strategy tailored to the patient's unique condition.

CyberKnife system for treatment

Treatment usually begins about one week after planning. Patients lie comfortably on the treatment table while the robotic CyberKnife system navigates around them, delivering precisely targeted radiation to the tumor. The procedure is pain-free, non-invasive, and does not require general anesthesia.

Benefits of CyberKnife treatment

With the help of cutting-edge technology, CyberKnife brings several advantages compared to conventional methods of cancer treatment:

• Shorter therapy time: CyberKnife therapy is finished in as little as one quick session per day for a maximum of five days.
• Comfortable therapy: CyberKnife requires no complicated treatment; all you need to do is lie comfortably on the treatment couch and allow it to work.
• Personalized treatment: To achieve the greatest results, your cancer treatment team in Turkey will adapt your care to the precise dimensions and form of your tumor.
• Preserves healthy cells: The system's extreme precision allows it to target the tumor with a deadly dosage of radiation while causing the least amount of damage to the surrounding tissues.

CyberKnife vs. conventional radiotherapy

Here's how the two approaches stack up:

In practice, that level of precision means treatment wraps up faster and stays more concentrated, usually with fewer complications and a better quality of life throughout care.

Reach out to our team to find out if CyberKnife is a good fit for your case, and get a free, personalized quote for your medical trip to Turkey.

What CyberKnife technology is used in Turkey?

Turkey's specialized centers mainly rely on the CyberKnife M6 by Accuray, one of the most advanced systems available in robotic radiosurgery today.

What that actually means for you:

• Sub-millimeter precision.
• A robotic arm that can shift treatment angles on the fly.
• Real-time tracking of your breathing throughout the session.
• No rigid head frame, no surgery involved.

The system delivers tightly targeted radiation doses with remarkable accuracy, often in just a handful of sessions, and typically without a long hospital stay.

CyberKnife M6 in Turkey: What the clinical results show

Turkish centers work predominantly with the CyberKnife M6, widely regarded as one of the top-performing robotic radiotherapy platforms in the world.

Here's what published medical research shows:

• Prostate cancer (SBRT): Over 90% recurrence-free survival at 5 years in low-risk patients, with serious complications remaining rare.
• Inoperable lung cancer: 92% local control, along with 74% overall survival at 2 years.
• Brain metastases: Around 92% local control at 3 months, and close to 79% overall survival at the same point.
• Liver cancer: Roughly 85% local control at 1–2 years, with minimal side effects.

Medical sources & references

The information on CyberKnife here draws from peer-reviewed studies and validated clinical outcomes. Main sources consulted:

• Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer: Long-Term Outcomes—covers 5-year recurrence-free survival rates and low toxicity in prostate SBRT.
• Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer—looks at local control and overall survival following CyberKnife treatment for inoperable lung cancer.
• CyberKnife Radiosurgery for Brain Metastases: Clinical Outcomes and Safety—reports on local control and survival outcomes for brain metastasis patients.
• Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: Local Control and Toxicity—evaluates local control and side effects in patients with inoperable liver cancer.